|
Volumn 98, Issue 22, 2001, Pages 12642-12647
|
The nature of the active suppression of responses associated with experimental autoimmune myasthenia gravis by a dual altered peptide ligand administered by different routes
a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
CHOLINERGIC RECEPTOR;
CYTOKINE;
GAMMA INTERFERON;
INTERLEUKIN 2;
LYSYLALANYL(VALYLISOLEUCYLVALYLLYSYLLEUCYLISOLEUCYLPROLYLSERYLTHREONYLSERYL SERYLALANYLVALYLASPARTYLTHREONYLPROLYLTYROSYLLEUCYLASPARTYLISOLEUCYLTHREONYLTYRO SYLHISTIDYLPHENYLALANYLVALYLALANYLGLUTAMYLARGINYLLEUCYLPROLYLLYSINE);
POLYPEPTIDE;
RECEPTOR SUBTYPE;
TRANSFORMING GROWTH FACTOR BETA;
UNCLASSIFIED DRUG;
AMINO ACID SUBSTITUTION;
ANIMAL CELL;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ANIMAL TISSUE;
ARTICLE;
AUTOIMMUNE DISEASE;
CLONAL ANERGY;
CONTROLLED STUDY;
CYTOKINE RELEASE;
FEMALE;
IMMUNE RESPONSE;
IN VITRO STUDY;
IN VIVO STUDY;
MOUSE;
MOUSE STRAIN;
MYASTHENIA GRAVIS;
NONHUMAN;
PRIORITY JOURNAL;
T LYMPHOCYTE ACTIVATION;
TH1 CELL;
TH2 CELL;
TORPEDO;
AMINO ACID SEQUENCE;
ANIMALS;
CYTOKINES;
FEMALE;
IMMUNIZATION;
INTERLEUKIN-2;
INTERLEUKIN-4;
MICE;
MICE, INBRED C57BL;
MOLECULAR SEQUENCE DATA;
MYASTHENIA GRAVIS;
PEPTIDE FRAGMENTS;
RECEPTORS, CHOLINERGIC;
T-LYMPHOCYTES;
TORPEDO;
TRANSFORMING GROWTH FACTOR BETA;
ANIMALIA;
|
EID: 0035940454
PISSN: 00278424
EISSN: None
Source Type: Journal
DOI: 10.1073/pnas.221456798 Document Type: Article |
Times cited : (41)
|
References (36)
|